Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis

Recruiting now

Conditions studied: Granulomatous Mastitis

In brief

Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tuberculosis drug therapy alone, and combined surgery with triple anti-tuberculosis drug therapy, with the goal of providing new insights for clinical treatment.

Key facts

Study ID

NCT06565845

Run by

First Affiliated Hospital of Harbin Medical University

People needed

350

Starts

2024-08-19

Expected to finish

2024-10-19

Last updated by the study team

2024-08-22

Who can join

Age: 15 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• non-lactating and aged 15-65 years
• histopathological confirmation of GLM
• normal liver and kidney function

You may not qualify if…

• lactating and pregnant women
• allergies to rifampin, isoniazid, or ethambutol
• concurrent malignant breast tumors
• severe underlying diseases
• other conditions deemed unsuitable by the investigator and
• refusal to participate in the study

Where it is running

• First affiliated hospital of Harbin medical university — Harbin, Heilongjiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.